BioWorld

Nov. 29, 2005

Targeted Genetics' Stock Surges On NIH Grant For HIV Vaccine

IDM Sells Assets To Pharmexa For $12M To Focus On Cancer

Other News To Note

ABI In $4B Merger With APP To Create Abraxis BioScience

American BioScience Inc. and its majority-owned subsidiary, American Pharmaceutical Partners Inc., are combining to create a new company, Abraxis BioScience. (BioWorld Today) Read More

Pfizer Begins Phase III Studies With Coley's NSCLC Therapy

Today's news in brief

BioWorld

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026

Emerging therapeutic strategies for Parkinson’s at ADPD 2026

BioWorld

Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...